The World Health Organization, with quiet but substantial backing from the UK government, is rolling out an accelerated response to the latest Ebola outbreak. Sources confirm that three separate vaccine candidates are now in parallel development, a move that signals the scale of concern behind closed doors.
Documents obtained by this newsroom show that the UK Department of Health and Social Care has committed an additional £45 million to the WHO's emergency vaccine fund. The money, routed through a little-known Geneva-based trust, is earmarked for fast-tracking clinical trials. A source close to the negotiations described the funding as 'unprecedented in both speed and secrecy.'
The three vaccines in question: one based on a modified vesicular stomatitis virus, similar to the Merck product used in previous outbreaks; another a chimpanzee adenovirus vector developed by the University of Oxford; and a third, more experimental, using mRNA technology from a British biotech firm. The latter has never been deployed in an active outbreak.
The WHO's official line remains measured. They speak of 'strengthening surveillance' and 'community engagement.' But the true picture, as always, lies in the contracts. We have seen the procurement orders. They include 500,000 doses of the Oxford vaccine, with options for a million more. That is not stockpiling for containment. That is preparation for a wider theatre.
Why the UK? The answer, as I have traced through a labyrinth of shell companies and government agencies, lies in the country's residual colonial health infrastructure in West Africa. British scientists maintain labs in Sierra Leone and Nigeria. They retain access to clinical data that others do not. And they have a vested interest: the outbreak's epicentre is within 200 miles of a major UK mining operation.
One whistleblower, speaking on condition of anonymity, told me: 'This isn't about saving lives. It's about saving assets. If the virus spreads to the capital, the mines shut down. The contracts dry up. The share prices collapse. The vaccines are insurance.'
I put this to the UK's Foreign Office. A spokesperson offered the standard response: 'The UK is committed to global health security. We are proud to support the WHO in its efforts to combat this deadly disease.' No denial. No details.
The WHO insists the vaccines will be distributed equitably. But I have seen the distribution plans. They prioritise regions where international staff are stationed. Local healthcare workers come second. It is the same pattern we saw in 2014. The same pattern we saw in the COVID pandemic. The whites get the shots first.
Let me be clear: vaccines are necessary. They will save lives. But the machinery behind them is the same machinery that extracts profit from crisis. The same suits who signed off on the funding will likely sit on the boards of the pharmaceutical companies that stand to gain billions in future sales.
This is a race. Not just against the virus, but against accountability. The trials are fast-tracked. The ethics committees are briefed. The papers are signed. And somewhere in a secure server, a trader is betting on the outcome.
We will continue to follow the money. We will publish the documents. Because in this game, the truth is the only vaccine that matters.
